Needle-Free Injection Systems Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, China, UK, Canada - Size and Forecast 2024-2028

Needle-Free Injection Systems Market Size 2024-2028

The needle-free injection systems market size is estimated to grow by USD 20.15 billion at a CAGR of 16.83% between 2023 and 2028. The increasing preference for minimally invasive biopsies is driving the market growth. For screening and diagnosis of various types of cancer, like bone cancer, biopsies are used. The traditional biopsy procedure is still widely used; however, it is invasive and can cause complications like bruising, swelling, bleeding, and infections. To prevent these complications, needle-free injections have emerged as an alternative; they involve non-invasive procedures to detect certain molecular biomarkers for the early detection of diseases in patients. They also have the advantages of quick results and minimal risks involved. All these features are expected to have a positive impact on the demand for needle-free injection systems. 

What will be the size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation

By End-user 

The market share growth by the hospitals and clinics segment will be significant during the forecast period. Needle-free injection systems are mostly used in hospitals to administer vaccines, anticoagulants, biologics, and other pharmaceutical drugs and there is an increasing demand for needle-free injection drug delivery from healthcare professionals. This is due to ease of administration and accurate dosing.

Get a glance at the market contribution of various segments View a PDF Sample

The hospitals and clinics segment was valued at USD 5.48 billion in 2018. Clinics and privately operated healthcare facilities that have highly skilled general medical practitioners offer diagnostic, therapeutic, or preventive healthcare treatment and care. The growth of this segment is due to the high number of hospital visits for treatment and the growing adoption of needle-free injection systems in hospitals and clinics, which are expected to propel the market growth during the forecast period.

By Product 

The fillable segment, not pre-filled with drugs is witnessing market growth due to its increased ease of storage. Unlike the pre-filled needle-free injection systems, these systems have drugs filled from separate vials or ampoules. However, pre-filled needle-free injection systems are expected to witness demand growth due to the convenience and accurate dosage of administration. This is likely to result in a slight decline in the market growth of the fillable segment of the market during the forecast period.

By Region

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period.

Within the region, the US is the largest market due to the widespread availability of insurance coverage and reimbursements and increasing R and D expenditure. The demand for self-administered drugs, increasing awareness about safe injectable technology, and high healthcare spending are also factors that are increasing the demand for the market in the US. Additional safety features and the presence of advanced medical facilities drive market growth, especially in states such as Indiana, Ohio, and Illinois. Besides the US, Canada is also a major revenue contributor due to the rapid adoption of advanced needle-free devices. Hence the above factors are likely to contribute to the growth of the regional market during the forecast period.

Buy Now Full Report and Discover More

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market vendors, including:

Antares Pharma Inc. - The company offers needle-free injection systems such as VIBEX and QuickShot.

• Aijex Pharma International Inc.
• AKRA DERMOJET
• Amico Group
• Becton Dickinson and Co.
• Endo International Plc
• Ferring BV
• Inovio Pharmaceuticals Inc.
• Lepu Medical Technology Beijing Co. Ltd.
• Medbitz Pte Ltd.
• Mika Medical Co.
• NuGen Medical Devices
• QUINOVARE and TECHiJET
• Technologies Médicales Internationales Inc.
• West Pharmaceutical Services Inc.
• Crossject
• Needle Free Injection System
• PharmaJet Inc.
• PORTAL INSTRUMENTS INC
• Recipharm AB

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market is witnessing a surge in demand, fueled by the growing prevalence of chronic diseases and the expanding geriatric population. These systems are instrumental in facilitating mass vaccination efforts, especially in combating communicable diseases while mitigating the risk of needlestick injuries. With the rise of biologics, innovative solutions like self injection devices, liquid based injectors, and laser powered needle are gaining traction. Additionally, options such as vibration based needle and fillable needle-free injectors provide versatility in drug delivery, catering to various medical needs in hospitals and clinics, home care, and research laboratories. Prefilled solutions like prefilled needle-free injectors streamline administration, while options like jet-based and disposable needle-free injectors offer convenience in vaccine delivery and insulin delivery, as well as specialized areas like oncology treatment.

Key Market Drivers

The increasing preference for minimally invasive biopsies is driving market growth. Biopsies are widely used for the early-stage detection of cancers and to help in diagnosis through procedures like fine-needle aspiration cytology (FNAC) biopsy, core needle biopsy, image-guided biopsy, and surgical biopsy procedures. Despite the vast usage and simplicity of traditional bone and other biopsy procedures, the prevalence of side effects has increased the demand for needle-free injection biopsies. A needle-free biopsy is a non-invasive procedure and is used to detect certain molecular biomarkers.

Additionally, the non-invasive nature, enhanced assessment of tumor heterogeneity, and the increasing possibility of performing regular follow-up examinations are among several advantages that shall result in the increasing adoption of needle-free biopsy testing for disease detection. Hence, due to the above factors, the growth of the market is likely to grow during the forecast period.

Significant Market Trends

The increasing incidence of needlestick infections is a key trend in the market. Needles are widely used in hospitals and clinics for the diagnosis, prevention, and treatment of infectious diseases. However, unsafe injection practices can leave patients vulnerable to infectious diseases. Usage of reused or contaminated needles and other unsafe injection practices have increased patient exposure and resulted in the contraction of infectious diseases, such as hepatitis B, hepatitis C, and human immunodeficiency virus (HIV).

Additionally, side effects like swelling, pain, rash, redness, or bleeding at the site of injection are common results of poor healthcare practices. Therefore, the safe usage of injectable medications by proper sterilization of needles for preventing infectious disease transmission is vital. Hence, the health risks associated with needle-administered injections shall provide opportunities for the global market to grow during the forecast period.

Major Market Challenges

Stringent regulations on medical devices are challenging market growth. This is greatly due to reported periodic recalls of products and regulatory issues over the years. Classification of medical devices as per the US FDA ranges from Class I (for relatively low-risk products) to Class III (that are subject to the highest level of scrutiny). Hence, needle-free injection systems must undergo standard clinical trials, which are time-consuming, expensive, and uncertain.

Additionally, failure at any single stage of the clinical trial can result in rejection. Furthermore, rules and regulations about approval processes regarding medical devices vary from country to country, and regulatory policies by government agencies, including the US FDA, are subject to frequent revision. In the case of product development during such revision of regulatory policies, it can pose a serious challenge to launching it in the market. Hence government and regulatory bodies formed regulations that can pose a restriction on the market growth during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Market Customer Landscape

Segment Overview

The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments. 

• End-user Outlook
  • Hospitals and clinics
  • Home care settings
  • Research laboratories

• Product Outlook 
  • Fillable
  • Pre-filled

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the World (ROW)
    • Australia
    • Argentina
    • Brazil

Market Analyst Overview

The market is witnessing rapid growth, driven by factors such as the increasing prevalence of chronic diseases and the growing geriatric population. These systems offer a solution to needlestick injuries and are particularly valuable in mass vaccination campaigns against communicable diseases like HIV/AIDS. With advancements in AI and bar code identification (BI), the administration of medications through self-injection devices becomes more efficient, especially with features like telecare and e-prescription. The market offers various options, including fillable needle-free injectors, microarray patches, and liquid-based injectors, catering to different drug delivery needs such as large molecule drugs for oncology and pain management. From subcutaneous to intradermal delivery, these systems ensure painless drug delivery and are increasingly utilized in homecare settings, driving the demand for vaccine and insulin delivery solutions.

Furthermore, the market is experiencing significant growth, driven by the rising demand for innovative drug delivery solutions. With the advent of self-injection devices and e prescription, patients are empowered to manage their health more effectively. Ensuring sterility is paramount in these systems, which encompass a wide range of options such as fillable needle free injectors, liquid-based injectors, and powder based injectors. Offering various administration routes like subcutaneous injectors, intramuscular injectors, and intradermal injectors, these systems cater to diverse medical needs. Prefilled options like Prefilled Needle Free Injectors streamline the delivery process, while advanced technologies, including Jet Based Needle, laser powered, and vibration based needles enhance user experience. Both disposable needle free injectors and reusable needle free injectors are available, supporting efficient vaccine delivery and comprehensive Drug delivery device systems.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch